Publicaties

Kenniscentrum
Jaar
Auteur

The Impact of Fluvoxamine on Clozapine and Norclozapine Serum Concentrations

Van Weringh, G., De Haas, H.J., De Haan, L., Touw, D.J. & De Koning, M.B.
Verschenen in European Journal of Drug Metabolism and Pharmacokinetics (2025)

Clinical treatment interventions in personal recovery stories of patients with severe mental illness: a qualitative study

Van Eck, R., Jelsma, A., Blondeel, J., de Wilde-Schutten, K., Zondervan, J.V.R., Burger, T., Vellinga, A., De Koning, M.B., Schirmbeck, F., Gerritsen, S., Kikkert, M.J. & De Haan, L.
Verschenen in Social Psychiatry and Psychiatric Epidemiology (2025)

A Cross-sectional Conceptual Replication and Longitudinal Evaluation of the PANSS-Autism-Severity-Score Measure Suggests it Does Not Capture Autistic Traits in Individuals With Psychosis

Chisholm, K., Schirmbeck, F., Pinkham, A.E., Sasson, N.J., Simons, C.J.P., De Haan, L., Harvey, P.D., Penn, D.L. & Ziermans, T.
Verschenen in Schizophrenia Bulletin (2023)

Age-Related Social Cognitive Performance in Individuals With Psychotic Disorders and Their First-Degree Relatives

Velthorst, E., Socrates, A., GROUP Investigators, Alizadeh, B.Z., van Amelsvoort, T., De Haan, L., Schirmbeck, F., van Os, J. & Fett, A.K.
Verschenen in Schizophrenia Bulletin, 49 (6), 1460-1469 (2023)

Risk factors for suicidality across psychosis vulnerability spectrum

Stephan, N.M., van Sprang, E.D., Wiebenga, J.X.M., Dickhoff, J., Schirmbeck, F., De Haan, L., van Amelsvoort, T., Veling, W. & Heering, H.D.
Verschenen in Schizophrenia Research, 261, 152-160 (2023)

Acceptance and Commitment Therapy for individuals at risk for psychosis or with a first psychotic episode: A qualitative study on patients’ perspectives

Bouws, J., Henrard, A., De Koning, M.B., Schirmbeck, F., van Ghesel Grothe, S., van Aubel, E., Reininghaus, U., De Haan, L. & Myin-Germeys, I.
Verschenen in Early Intervention in Psychiatry, 1-10 (2023)

Personal recovery suits us all: A study in patients with non-affective psychosis, unaffected siblings and healthy controls

Van Eck, R., van Velden, J., Vellinga, A., van der Krieke, L., Castelein, S., van Amelsvoort, T., Bruggeman, R., Cahn, W., Simons, C.J.P., van Os, J., De Haan, L. & Schirmbeck, F.
Verschenen in Schizophrenia Research, 255, 24-32 (2023)

Associations between genetic liabilities to smoking behavior and schizophrenia symptoms in patients with a psychotic disorder, their siblings and healthy controls

Lin, B.D., Vermeulen, J.M., Bolhuis, K., Chang, X., Schirmbeck, F., GROUP Investigators, Blankers, M., De Haan, L. & Luykx, J.J.
Verschenen in Psychiatry Research, 323 (2023)

Oxidative stress in psychosis: a new target for intervention?

Hagen, J., Sutterland, A.L., Wezenberg, B.N., Tan, H.L. & De Haan, L.
Verschenen in Tijdschrift Voor Psychiatrie, 64 (1), 38-42 (2022)

Individualized prediction of three- and six-year outcomes of psychosis in a longitudinal multicenter study: a machine learning approach

de Nijs, J., Burger, T., Janssen, R.J., Mostafa Kia, S., van Opstal, D.P.J., De Koning, M.B., De Haan, L., GROUP Investigators, Cahn, W. & Schnack, H.G.
Verschenen in Nature: Schizophrenia (2021)

To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial

Begemann, M.J.H., Thompson, I.A., Veling, W., Gangadin, S.S., Geraets, C.N.W., van 't Hag, E., Müller-Kuperus, S.J., Oomen, P.P., Voppel, A.E., van der Gaag, M., Kikkert, M.J., van Os, J., HAMLETT Group, De Haan, L. & Sommer, I.E.C.
Verschenen in Trials, 21, 147 (2021)

Tapering antipsychotic medication: practical considerations

Horowitz, A., Moncrieff, J., De Haan, L., Bogers, J.P.A.M., Gangadin, S.S., Kikkert, M.J., Veling, W. & Sommer, I.E.C.
Verschenen in Psychological Medicine, 52 (1) (2021)

Ethnic discrimination and depressed mood: The role of autonomic regulation

Hagen, J., Sutterland, A.L., Collard, D., de Jonge, C.D.E., van Zuiden, M., Zantvoord, J.B., De Haan, L., Lok, A. & et al.
Verschenen in Journal of Psychiatric Research, 144, 110-117 (2021)

Medication strategies in first episode psychosis patients: A survey among psychiatrists

Kikkert, M.J., Veling, W., De Haan, L., Begemann, M.J.H., De Koning, M.B., HAMLETT and OPHELIA Consortium & Sommer, I.E.
Verschenen in Early Intervention in Psychiatry, 1-8 (2021)

Skin autofluorescence of advanced glycation end products and mortality in affective disorders in the lifelines cohort study: A mediation analysis

Hagen, J., Sutterland, A.L., Liefers, T., Schirmbeck, F., Cohn, D.M., Lok, A., Tan, H.L.O., Zwinderman, A.H. & De Haan, L.
Verschenen in Journal of Affective Disorders, 282, 1082-1089 (2021)

A comparison of depressive symptom profiles between current major depressive disorder and schizophrenia spectrum disorder

Lange, S.M.M., Schirmbeck, F., Stek, M.L., Murk Jansen, Y.R., van Rooijen, G., De Haan, L., Penninx, B.W.J.H. & Rhebergen, D.
Verschenen in Journal of Psychiatric Research, Volume 135, 143-151 (2021)
ISO 9001 HKZNEN7510 Keurmerk

Disclaimer | Privacyverklaring | Cookiebeleid | © 2025 Arkin Onderzoek - Alle rechten voorbehouden | Realisatie: Lemon

Arkin